This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance: Archive
Unum Group Trades Above 200-Day SMA: Time to Buy or Hold the Stock?
by Zacks Equity Research
UNM eyes premium and earnings growth in 2026, backed by strong sales trends, persistency and expanding product lines.
AFLPositive Net Change UNMPositive Net Change AMSFPositive Net Change GLPositive Net Change
insurance
NMIH Stock Trading at a Discount to Industry at 1.08X: Time to Hold?
by Zacks Equity Research
NMI Holdings remains poised to gain from higher new insurance written volume, a comprehensive reinsurance program and prudent capital deployment.
RNRPositive Net Change AXSPositive Net Change FAFPositive Net Change NMIHPositive Net Change
insurance
Lemonade Stock Plunges 16% in 3 Months: Time to Buy the Dip?
by Tanuka De
Lemonade shares slid 15.9% in 3 months. AI-driven growth, rising in-force premium and 2026 revenue outlook clash with a premium valuation.
EVERPositive Net Change LMNDPositive Net Change ROOTPositive Net Change
insurance
ACGL's Solid Growth Comes With a Premium Valuation: Hold or Buy?
by Zacks Equity Research
Arch Capital benefits from strong premium growth, rising investment income and favorable P&C market trends that support long-term expansion.
WRBPositive Net Change PGRPositive Net Change ACGLPositive Net Change
insurance
Is THG Expanding Its Motorcycle & ORV Insurance Offerings?
by Zacks Equity Research
Hanover expands motorcycle and ORV insurance into more states, adding premium features to boost cross-selling and deepen customer ties.
ALLPositive Net Change PGRPositive Net Change THGPositive Net Change
insurance
Here's Why Investors Should Stay Neutral on CNO Financial for Now
by Zacks Equity Research
CNO's sales growth, Medicare momentum and AI investments support gains, but rising expenses and high leverage may limit upside.
CNOPositive Net Change OSGPositive Net Change FAFPositive Net Change THGPositive Net Change
artificial-intelligence finance insurance medical smart-health
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now
by Zacks Equity Research
MD gains from stronger cash collections, payer mix and acquisitions, while telehealth expansion and buybacks support growth.
MDPositive Net Change WSTPositive Net Change GMEDPositive Net Change BTSGNegative Net Change
artificial-intelligence insurance medical smart-health
RLI Boosts Shareholder Value With Dividends, Approves Buyback Program
by Zacks Equity Research
RLI's board of directors approves a $2 special dividend, raises the quarterly payout by 12.5%, and authorizes a $250M buyback, extending its payout streak.
RLIPositive Net Change TRVPositive Net Change FAFPositive Net Change SLFPositive Net Change
insurance
New Strong Buy Stocks for May 15th
by Zacks Equity Research
SNX, HG, LSCC, ALRS and LXFR have been added to the Zacks Rank #1 (Strong Buy) List on May 15th, 2026.
LSCCNegative Net Change SNXNegative Net Change LXFRPositive Net Change ALRSPositive Net Change HGPositive Net Change
finance insurance semiconductor
Here's Why You Should Keep Holding Aflac in Your Portfolio
by Zacks Equity Research
AFL is seeing strong sales growth in Japan and the U.S., improving Japan margins and a lower benefit ratio, though premium valuation pressure remains.
AFLPositive Net Change RDNPositive Net Change HGPositive Net Change SLDEPositive Net Change
finance insurance